When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Nearly all men can stand adversity, but if you want to test a man's character, give him power." - Abraham Lincoln
It has been a tough start to 2020 for Stemline Therapeutics (STML), or at least its stock. The shares dropped some 35% on January 13th when the company provided preliminary fourth quarter revenue guidance for recently approved ELZONRIS that did not live up to expectations. In this article, we take a look at recent events and update the investment case on Stemline in the paragraphs below.